互白素10:弥合多发性骨髓瘤免疫场景中的沟
Queenie Fernandes1, Abdul W Ansari2, Karama Makni-Maalej1
1Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
International review of cell and molecular biology
|February 12, 2025
概括
介质素10 (IL-10) 在多发性骨髓瘤 (MM) 进展,免疫逃避和治疗耐药性方面发挥着关键作用. 了解IL-10的影响为MM患者提供了新的诊断和治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有显著发病率的血细胞恶性瘤.
- 介素10 (IL-10) 是一种细胞因子,与MM病理生物学有关.
- 在MM中,IL-10影响瘤生长,免疫逃避和药物耐药性.
研究的目的:
- 探索IL-10在MM中的多方面的作用.
- 为了研究IL-10在骨髓微环境中的相互作用.
- 评估IL-10作为MM中的生物标志物和治疗点.
主要方法:
- 文献综述综合了MM中IL-10的当前研究.
- 对IL-10与免疫细胞相互作用的分析.
- 评估IL-10的预后,诊断和治疗影响.
主要成果:
- IL-10有助于MM的进展和免疫抑制.
- IL-10水平与MM患者的结果相关.
- 向IL-10呈现出潜在的治疗策略.
结论:
- IL-10是MM病变和进展的关键因素.
- 作为MM诊断和预后的循环生物标志物,IL-10具有前景.
- 准IL-10通路可能为MM治疗提供新的治疗途径.
相关概念视频
T Cell Types and Functions
938
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
938
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cytotoxic T Cells-mediated Immune Response
832
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
832
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464


